---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-23-000111"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T19:30:47.663775+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics reports record Q3 revenue of $40.0M, up 14% YoY; raises adj. EBITDA guidance

## Summary
- Total revenue $40.0M (+14% YoY); U.S. revenue $29.4M (+11%), international $10.6M (+26%).
- Trauma & Deformity revenue $28.8M (+21%); Scoliosis $10.3M (+3%); Sports Med/Other $0.9M (-20%).
- Net loss of $4.6M vs net income of $18.5M in prior year; adjusted EBITDA record $3.6M (vs $1.9M).
- Full-year 2023 revenue guidance reiterated at $148-151M; adj. EBITDA guidance raised to $4-5M.
- Consigned $3.9M of sets in Q3 (vs $6.4M in Q3 2022); cash $84.0M with no credit line drawn.

## SEC filing metadata
- accession: 0001425450-23-000111
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000111/0001425450-23-000111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000111/kids-20231106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-23-000111
- JSON: https://secwatch.observer/filing/0001425450-23-000111.json
- Plain text: https://secwatch.observer/filing/0001425450-23-000111.txt

## Key facts
- Earnings Releases
  ORTHOPEDIATRICS CORP updated its the third quarter ended September 30, 2023 guidance (reaffirmed).
  - Period: the third quarter ended September 30, 2023
  - Guidance: reaffirmed
  - Result: reported results
  source text: OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended September 30, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000111/0001425450-23-000111-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.